| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |